Skip to content

ROIV

Roivant Sciences Ltd.

NASDAQ · GBHealthcareBiotechnology
$34.05-1.33%

Price as of Jul 20, 2026

ROIV capital

Roivant Sciences Ltd. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.02x
Net debt / equity
-0.29x
Debt / assets
0.02x
Debt / EBITDA
-0.41x
Net debt / EBITDA
5.04x

Liquidity & coverage

Current ratio
18.37x
Quick ratio
18.37x
Cash ratio
15.27x
Interest coverage
EBITDA / interest
Working capital
$4.9B

Cash & dividend

FCF / debt
-7.06x
Cash flow / debt
-6.98x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.